MedPath

海南锦瑞制药有限公司

Ownership
-
Established
2008-04-07
Employees
-
Market Cap
-
Website
http://www.hnjrzy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

29

NMPA:29

Drug Approvals

Montelukast Sodium Chewable Tablets

Product Name
孟鲁司特钠咀嚼片
Approval Number
国药准字H20253265
Approval Date
Jan 24, 2025
NMPA

Irinotecan Hydrochloride Injection

Product Name
盐酸伊立替康注射液
Approval Number
国药准字H20143127
Approval Date
Jan 23, 2024
NMPA

Irinotecan Hydrochloride Injection

Product Name
盐酸伊立替康注射液
Approval Number
国药准字H20143126
Approval Date
Jan 23, 2024
NMPA

Pantoprazole Sodium for Injection

Product Name
注射用泮托拉唑钠
Approval Number
国药准字H20143058
Approval Date
Jan 5, 2024
NMPA

Pantoprazole Sodium for Injection

Product Name
注射用泮托拉唑钠
Approval Number
国药准字H20143057
Approval Date
Jan 5, 2024
NMPA

Oxaliplatin for Injection

Product Name
注射用奥沙利铂
Approval Number
国药准字H20143023
Approval Date
Jan 3, 2024
NMPA

Oxaliplatin for Injection

Product Name
注射用奥沙利铂
Approval Number
国药准字H20143024
Approval Date
Jan 3, 2024
NMPA

Pemetrexed Disodium for Injection

Product Name
注射用培美曲塞二钠
Approval Number
国药准字H20163005
Approval Date
Oct 23, 2023
NMPA

Pemetrexed Disodium for Injection

Product Name
注射用培美曲塞二钠
Approval Number
国药准字H20143014
Approval Date
Oct 23, 2023
NMPA

Pemetrexed Disodium for Injection

Product Name
注射用培美曲塞二钠
Approval Number
国药准字H20143013
Approval Date
Oct 23, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.